Related Experiment Video
Updated: May 31, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Identifiability in biobanks: models, measures, and mitigation strategies
Bradley Malin1, Grigorios Loukides, Kathleen Benitez
1Department of Biomedical Informatics, School of Medicine, Vanderbilt University, 2525 West End Avenue, Suite 600, Nashville, TN 37203, USA. b.malin@vanderbilt.edu
Person-specific biospecimens raise privacy concerns. This review assesses the identifiability of biospecimens and data in biobanks, exploring risks, contributing factors, and mitigation strategies for enhanced security.
Area of Science:
- Bioethics
- Genomic Data Privacy
- Biorepository Management
Background:
- The increasing collection and sharing of person-specific biospecimens and associated data in biobanks present significant privacy challenges.
- A key concern is the identifiability of individuals, i.e., the ability to link biospecimens and data back to the donor.
- Existing biobank policies require re-evaluation in light of evolving data sharing practices and technological advancements.
Purpose of the Study:
- To review the extent to which biospecimens and associated data can be identified.
- To assess the current research on identifiability of DNA sequence, demographic, and clinical data within biobanks.
- To inform policy development regarding biobank security and data access.
Main Methods:
- Literature review of recent research on identifiability assessment.
- Analysis of factors contributing to the variability of identifiability risk.
- Examination of data sharing scenarios and biorepository practices.
Main Results:
- The degree of identifiability risk associated with biospecimens and data is highly variable.
- Identifiability is influenced by factors including data type, data completeness, and analytical methods used.
- Potential strategies for risk mitigation and management have been identified.
Conclusions:
- Understanding and managing identifiability risk is crucial for maintaining public trust in biobanking.
- Biobank security and access policies must be updated to reflect the complexities of data identifiability.
- Further research and clear guidelines are needed to balance data sharing for research with individual privacy protection.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Methods of Classification and Identification